Peak Bio, Inc.
PKBODelisted Mar 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001834645
Peak Bio, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Dec 4, 2024; 9 institutions reported holding it in 13F filings for Q4 2022, worth $2.53M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Peak Bio, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
PKBO is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022
- Institutional holders
- 0
- −1 vs. Q1 2023
- Shares held
- 0
- −497.5K (−100.0%) vs. Q1 2023
- Total value
- $0
- −$314.1K (−100.0%) vs. Q1 2023
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PKBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 1 | $314.1K |
| Q4 2022 | 9 | $2.53M |
| Q3 2022 | 1 | $30.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Peak Bio, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Palo Alto Investors LP | 0 | $0 | 0.00% | −497,528−100.0% | Sold out |